<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Quantum Discovery Labs &#187; anti-viral compounds</title>
	<atom:link href="http://q-pharm.com/tag/anti-viral-compounds/feed/" rel="self" type="application/rss+xml" />
	<link>http://q-pharm.com</link>
	<description>The drug discovery company</description>
	<lastBuildDate>Fri, 03 Feb 2012 10:47:43 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.2.1</generator>
		<item>
		<title>Drug resistance: evolution in action</title>
		<link>http://q-pharm.com/2010/01/drug-resistance-evolution-in-action/</link>
		<comments>http://q-pharm.com/2010/01/drug-resistance-evolution-in-action/#comments</comments>
		<pubDate>Wed, 06 Jan 2010 08:40:08 +0000</pubDate>
		<dc:creator>Peter Fedichev, Quantum CTO</dc:creator>
				<category><![CDATA[antiviral]]></category>
		<category><![CDATA[flue]]></category>
		<category><![CDATA[Quantum Software]]></category>
		<category><![CDATA[selectivity]]></category>
		<category><![CDATA[anti-viral compounds]]></category>

		<guid isPermaLink="false">http://q-pharm.com/?p=176</guid>
		<description><![CDATA[Introduction of drugs puts an evolutionary pressure on viruses and makes the viral proteins evolve. On the other hand, the change in the protein structure should be compatible with the [...]


Related posts:<ol><li><a href='http://q-pharm.com/2011/12/map17-hiv-matrix-protein-is-a-promising-target-for-drug-discovery/' rel='bookmark' title='MA/p17 HIV matrix protein is a promising target for drug discovery'>MA/p17 HIV matrix protein is a promising target for drug discovery</a></li>
<li><a href='http://q-pharm.com/2007/09/quantum-and-albumin-binding-calculations-the-role-of-protein-flexibility/' rel='bookmark' title='QUANTUM and HSA binding calculations: the role of protein flexibility'>QUANTUM and HSA binding calculations: the role of protein flexibility</a></li>
<li><a href='http://q-pharm.com/2008/09/whats-an-ultimate-value-of-reversible-drug-binding-constant/' rel='bookmark' title='What&#8217;s an ultimate value of reversible drug binding constant?'>What&#8217;s an ultimate value of reversible drug binding constant?</a></li>
<li><a href='http://q-pharm.com/quantum-discovery-services/drug-design-drug-development-bioinformatics-and-preclinical-services/' rel='bookmark' title='Drug design, drug development, bioinformatics and preclinical services'>Drug design, drug development, bioinformatics and preclinical services</a></li>
<li><a href='http://q-pharm.com/2010/07/new-inhibitors-of-reca-bacterial-sos-response-system-identified/' rel='bookmark' title='New inhibitors of RecA (bacterial SOS response system) identified.'>New inhibitors of RecA (bacterial SOS response system) identified.</a></li>
</ol>

Related posts brought to you by <a href='http://yarpp.org'>Yet Another Related Posts Plugin</a>.]]></description>
		<wfw:commentRss>http://q-pharm.com/2010/01/drug-resistance-evolution-in-action/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
	</channel>
</rss>

